RE: Phase II to start for ExherinOk SS, I'll agree with you on the fact that the length of time that this is taking is much too long, but today's announcement is very encouraging indeed. I especially enjoyed this statment contained within the news release.
"That trial, which is enrolling patients at the Ottawa Regional Cancer Centre and the MD Anderson Cancer Center, has demonstrated that Exherin(TM) has a satisfactory safety and pharmacokinetic profile and has shown evidence of anti-tumor activity, all of which is encouraging us to accelerate the clinical development of this drug. This Phase Ib/II study uses a weekly dosing schedule and thus should provide important information on another way to give Exherin(TM)."
I've no intention at this point of bailing on this as I've been here for a few years and still feel very encouraged with the possibility that there could be somthing groundbreaking here, and if that happens everyone will know who Adherex is.
Regards, DH